Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of Cladribine in Relapsing Multiple Sclerosis
DRKS00017583Phase 4Terminated
- Sponsor
- Universität Münster
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of cladribine in multiple sclerosis (MS), sponsored by Universität Münster. Started Aug 2019; status: terminated.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on DRKS00017583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017583.